Author:
Baars A.,Claessen A.M.E.,van den Eertwegh A.J.M.,Gall H.E.,Stam A.G.M.,Meijer S.,Giaccone G.,Meijer C.J.L.M.,Scheper R.J.,Wagstaff J.,Vermorken J.B.,Pinedo H.M.
Reference28 articles.
1. Cutaneous Melanoma;Balch,1997
2. Interferon-α2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684;Kirkwood;J Clin Oncol,1996
3. Preliminary analysis of the E1690/S9111/C9190 intergroup postoperative aduvant trial of high- and low-dose IFN-α2b (HDI and LDI) in high-risk primary or lymphenode metastatic melanoma;Kirkwood;ASCO,1999
4. New approaches in the systemic treatment of melanoma;Chowdhury;Cancer Treat Rev,1999
5. The national cancer data base report on cutaneous and non-cutaneous melanoma: A summary 84.836 cases from the past decade;Chang;Cancer,1998
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献